Evolus, Inc.
Industry: Life Sciences ・ $EOLS on Nasdaq
Insider Sale
+$86,431
-0.9%
Shares
Shares Volume: 6,236 Shares
Average Share Price: $13.86
INSIDER
MOATAZEDI DAVID
See Remarks (Director)
reported on Mar 29 2024
traded on Mar 27 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 689,614 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $500,447.18 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 1 / 13 |
| P/S VALUE RATIO | 0.399 |
| AVERAGE SALE VALUE | $249,698.09 |
| COMPANY PREVIOUS TRADES |